NEWS
ACCC overstates chemist merger risks claims Barrenjoey
MELBOURNE: The competition regulator entirely ignored a major wholesaler when it warned that ... read more
Telix pulls $300m Nasdaq IPO as investors demand deep discount
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 ... read more